Imetelstat: Completed Phase II enrollment

Geron completed enrollment of 166 patients with locally recurrent or metastatic breast cancer in an open-label Phase II trial comparing 300 mg/m 2 imetelstat on day 1 of a 21-day cycle plus paclitaxel...